Clinical trial
A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
NCT01838642 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2013
- Completion date
- January 31, 2016
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.